|
Market Cap (10-Jun) $44,934,040 (0th) |
Close (30-Jun) $0.105 |
Volume (30-Jun) 1,951,148 |
Shortsold (26-May) 2,077,074 (0.06%) (491st) |
|
52w High $0.040 |
52w Low $0.017 |
P/E - |
EPS -0.02 |
RAD released this announcement to the ASX on 16 September 2022, 14:08. The announcement is not marked as price sensitive, and is 3 page(s) in length and 165.37kb in size.
You can view all announcements from RAD and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAD was 0.236% short sold according to ASIC data. It was ranked the 413th most shorted stock on the ASX. It remains ranked 491st as of the latest reported data (26 May 2026).
| Other Recent Announcements from RAD | |
|---|---|
| Notification of cessation of securities - RAD | 30 June 2023, 14:57 |
| Notification regarding unquoted securities - RAD | 30 June 2023, 14:53 |
| Pivalate educational webinar 14 June 2023 | 13 June 2023, 8:39 |
| FDA grants pediatric disease designation for DUNP19-revised | 16 September 2022, 14:08 |
| FDA grants rare pediatric disease designation for DUNP19 | 16 September 2022, 11:57 |
| JV with MD Anderson to develop novel radiopharmaceuticals | 14 September 2022, 9:22 |
| FDA grants Orphan drug status to RAD DUNP19 for Osteosarcoma | 9 September 2022, 8:58 |
You must be logged in to post a reply.
